The global recombinant coagulation factors market has witnessed major growth over the past few years. The growth of this market is mainly due to increasing number of hemophilia patients, growing diagnosis rates, and rising number of research and development on coagulation factors. In addition, increasing prophylactic treatment for hemophilia across the globe is further expected to drive the growth of this market. However, high cost of hemophilia treatment and low cost plasma coagulation factor alternatives to recombinant coagulation factors are hampering the growth of this market. Many players are focusing on Asia Pacific region to expand their businesses as this market is most lucrative for the recombinant coagulation factors.
https://www.meticulousresearch.com/increasing-hemophilia-patients-diagnosis-rate-and-growing-prophylactic-treatment-pivotal-factors-for-the-growth-of-recombinant-coagulation-factors-market/
No comments:
Post a Comment